Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity.

Goldstein D, Sosman JA, Hank JA, Weil-Hillman G, Moore KH, Borchert A, Bechhofer R, Storer B, Kohler PC, Levitt D
Cancer Res. 1989 49 (23): 6832-9

PMID: 2819723

MeSH Terms (17)

Adult Antigens, CD Antigens, Differentiation, T-Lymphocyte Cytotoxicity, Immunologic Dose-Response Relationship, Drug Drug Administration Schedule Female Humans Interleukin-2 Killer Cells, Lymphokine-Activated Killer Cells, Natural Leukocyte Count Lymphocyte Activation Male Middle Aged Outpatients Time Factors

Connections (1)

This publication is referenced by other Labnodes entities: